Target intelligence / Profile preview

Systemic potassium ion homeostasis

Molecular classification
Biological process, Other
01

Overview

Systemic potassium ion homeostasis is the physiological process of maintaining potassium concentrations within a narrow range (typically 3.5–5.0 mEq/L) through a balance of dietary intake, distribution between intracellular and extracellular fluid, and renal excretion (StatPearls, 2023). As the primary intracellular cation, potassium is essential for maintaining the resting membrane potential of cells, which is vital for normal cardiac rhythm and neuromuscular function (NIH, 2022). Dysregulation of this system results in hyperkalemia or hypokalemia, both of which are associated with increased mortality due to life-threatening cardiac arrhythmias (Nature Reviews Nephrology, 2017). While systemic potassium ion homeostasis is a biological process rather than a single molecular target, it is the functional objective of many therapeutic interventions. Drugs such as loop diuretics, potassium-sparing diuretics, and RAAS inhibitors modulate this system by targeting specific proteins like the Na-K-2Cl cotransporter or the mineralocorticoid receptor (PubMed, 2021). Effective management of potassium balance is critical in patients with chronic kidney disease or heart failure to prevent severe electrolyte imbalances (Journal of the American Society of Nephrology, 2020).

Other names
Potassium homeostasisPotassium balanceK+ regulationPotassium metabolism
02

Mechanism of action

Modulation of renal potassium excretion and transcellular shifting via inhibition of transporters (e.g., NKCC2, NCC), ion channels (e.g., ROMK), or hormonal pathways (e.g., RAAS).

03

Biological functions

Electrolyte balanceMembrane potential maintenanceCardiac rhythm regulationNeuromuscular transmissionAcid-base balanceOther
04

Disease associations

HyperkalemiaHypokalemiaHypertensionCardiac arrhythmiaChronic kidney diseaseCardiovascular diseaseOther
05

Safety considerations

Risk of fatal cardiac arrhythmiasSudden cardiac arrestMuscle paralysisRenal impairment complicationsDrug-induced electrolyte imbalance
06

Interacting drugs

Furosemide

6 more in the full profile.

07

Biomarkers

Serum potassium concentrationUrinary potassium excretionTranstubular potassium gradient (TTKG)Electrocardiogram (ECG) changes

Beyond the preview

Go deeper on Systemic potassium ion homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic potassium ion homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call